TC Biopharm (Holdings) Revenue

Revenue

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

114.91K USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	3.84M	1.87M	94.30%
Dec 31, 2021	1.98M	-	-
Dec 31, 2020	1.98M	-1.45M	-42.26%
Dec 31, 2019	3.43M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
Veradigm	588.02M
Glass House Brands	200.90M
Elite Pharmaceuticals	70.00M
Northwest Biotherapeutics	1.38M
BioStem Technologies	301.83M
American Oncology Network	1.76B
Silence Therapeutics	43.26M

Revenue Rankings

TC Biopharm (Holdings) News

18 days ago - TCBP Announces Grant of European Patent for Targeting of Microbial, Oncological, and Viral Indications using Modified Gamma Delta T Cells - PRNewsWire
5 weeks ago - TCBP Announces Transition from Nasdaq to OTC Markets - PRNewsWire
5 weeks ago - TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead - PRNewsWire
7 weeks ago - TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - PRNewsWire
2 months ago - TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PRNewsWire
2 months ago - TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial - PRNewsWire
2 months ago - TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial - PRNewsWire
2 months ago - TCBP to Implement ADS Ratio Change - PRNewsWire

More News